Skip to main content
PingMeDoc
Prescription requiredEris Life Sciences Pvt LtdAnti-diabetic

Glimisave Mv 3.3

Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg)

Glimisave Mv 3.3 is used for glimisave MV 3.3 Tablet SR is used in the treatment of type 2 diabetes.

Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated September 2026

₹165
Licensed pharmacyPharmacist-verified orderDelivered across India

Key details

Salt: Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg)
Available variants: NA 10`S
Best price: ₹165
Prescription: Required
Manufacturer: ERIS LIFE SCIENCES PVT LTD

Ordering notes

Standard delivery across India. No same-day delivery nationally.
Chennai express delivery is possible and chargeable. Learn more
Returns & refunds: orders can be cancelled before dispatch; after dispatch, returns depend on the item category. Read the full policy

Composition of Glimisave Mv 3.3

Glimisave Mv 3.3 contains Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg). It belongs to the Biguanide, Oral anti-diabetic and Sulfonylurea class of medicines.

Uses of Glimisave Mv 3.3

Glimisave MV 3.3 Tablet SR is used in the treatment of type 2 diabetes.

Key benefits

  • First-choice medicine for type 2 diabetes
  • Does not usually cause weight gain
  • Low risk of hypoglycaemia when used alone
  • Targets the after-meal sugar rise
  • Can be combined with other diabetes medicines
  • Lowers blood sugar quickly
  • Long-established and inexpensive

How Glimisave Mv 3.3 works

Glimisave MV 3.3 Tablet SR is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.

How to take Glimisave Mv 3.3

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave MV 3.3 Tablet SR is to be taken with food.Glimisave MV 3.3 Tablet SR may cause stomach upset if taken on empty stomach.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause a dangerous build-up of acid in the blood, with vomiting, severe weakness and laboured breathing. It may cause low blood sugar and marked stomach upset. It can cause severe and prolonged low blood sugar, which may lead to fits or unconsciousness. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Glimisave Mv 3.3

Most side effects of Glimisave Mv are mild and settle as the body adjusts. Reported side effects include:

  • Hypoglycemia (low blood sugar level) Nausea Diarrhea Taste change Flatulence Stomach pain Headache Skin rash Respiratory tract infection

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Glimisave Mv 3.3

PregnancyGlimisave MV 3.3 Tablet SR may be unsafe to use during pregnancy.<br>Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
BreastfeedingGlimisave MV 3.3 Tablet SR is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
AlcoholTaking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
DrivingMay cause drowsiness or affect your concentration. Do not drive until you know how it affects you.
KidneyGlimisave MV 3.3 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glimisave MV 3.3 Tablet SR may be needed. Please consult your doctor.<br>Use of Glimisave MV 3.3 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
LiverGlimisave MV 3.3 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimisave MV 3.3 Tablet SR may be needed. Please consult your doctor.<br>Glimisave MV 3.3 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Habit formingNo

Warnings and precautions

Stomach upset is common in the first two weeks and usually settles; taking it with food helps. Tell your doctor before any surgery or a scan that uses contrast dye — this medicine is usually stopped for a short time around them. Stop and seek urgent care if you develop deep rapid breathing, severe weakness, muscle pain or vomiting with cold clammy skin. This is rare but serious. Long-term use can lower vitamin B12, so your doctor may check it from time to time. If you feel shaky, sweaty, confused or unusually hungry, take sugar, glucose or a sweet drink at once and tell your doctor — these are signs your blood sugar has fallen too low. If a low-sugar episode happens while on an alpha-glucosidase inhibitor such as voglibose or acarbose, use glucose — ordinary sugar and sweets work more slowly. Tell your doctor about any new swelling of the ankles, breathlessness or sudden weight gain. Do not skip meals while on this medicine — a missed meal is the commonest cause of a low-sugar episode. Carry glucose, sugar or sweets with you, and tell the people you live and work with what a low-sugar episode looks like. Older people and people with kidney trouble are more likely to have low sugar, and may need a smaller dose.

Do not take Glimisave Mv if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for people with severe kidney disease, severe liver disease, or an acute illness causing dehydration. Not for people who have had diabetic ketoacidosis. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with heart failure, active bladder cancer or unexplained blood in the urine. Not for people with severe kidney or liver disease.

Interactions with other medicines

Tell your doctor about water tablets, steroids, and any contrast dye scan. Alcohol increases the risk of the rare acid build-up and should be limited. Low blood sugar is more likely when combined with insulin or a sulfonylurea. Many medicines change how strongly this works — tell your doctor about aspirin, blood thinners, antifungals, sulfa antibiotics and beta blockers in particular. Beta blockers can mask the warning signs of low blood sugar.

How to store Glimisave Mv 3.3

Store below 30°C in the original pack, away from direct sunlight and moisture. Keep out of the reach of children.

Expert advice for Glimisave Mv 3.3

Take it with or just after food to reduce stomach upset. Keep taking it even when your sugar readings look normal — that is the medicine working. Continue your diet and physical activity; this medicine works alongside them, not instead of them. Take it with the first mouthful of your meal so it can act on that meal. Expect some wind in the first weeks; it usually settles. Take it shortly before a meal, and eat that meal. Check your sugar as often as your doctor has asked, especially when your routine changes.

Manufacturer and class

Manufacturer:
ERIS LIFE SCIENCES PVT LTD
Therapeutic class:
Anti-diabetic
Drug class:
Biguanide, Oral anti-diabetic and Sulfonylurea

Substitutes for Glimisave Mv 3.3

Medicines with the same active ingredient (Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg)). Ask your doctor or pharmacist before switching brands.

MedicinePackPricevs Glimisave Mv 3.3
Glimzab Mv3 TabletNEUCURE HEALTHCARE PVT LTDtablet · 15`S₹29076% more
Glimzab Mv3 Forte TabletNEUCURE HEALTHCARE PVT LTDtablet · 15`S₹29176% more
See all substitutes and alternatives

More from Eris Life Sciences Pvt Ltd

View categories
Advog 0.2
Rx

Advog 0.2

Eris Life Sciences Pvt Ltd - 10 S

₹103

Prescription required

Rx

Advog 0.3

Eris Life Sciences Pvt Ltd - 10 S

₹164

Prescription required

Rx

Advog M 0.2+

Eris Life Sciences Pvt Ltd - 10 S

₹122

Prescription required

Rx

Advog M 0.3 +

Eris Life Sciences Pvt Ltd - 10 S

₹142

Prescription required

Rx

Aim 7- 30 XR

Eris Life Sciences Pvt Ltd - 15 S

₹161

Prescription required

Aim 7- 60 XR Tab
Rx

Aim 7- 60 XR Tab

Eris Life Sciences Pvt Ltd - Tablet - 15 S

₹231

Prescription required

Alerfix
Rx

Alerfix

Eris Life Sciences Pvt Ltd - 10 S

₹65

Prescription required

Alerfix M
Rx

Alerfix M

Eris Life Sciences Pvt Ltd - 15 S

₹286

Prescription required

More in Metformin

View categories
Ace Revelol 25/2.5
Rx

Ace Revelol 25/2.5

IPCA Laboratories Ltd - 10 S

₹211

Prescription required

Bylenta D Tab
Rx

Bylenta D Tab

Lloyd Healthcare - Tablet - 10 S

₹192

Prescription required

Dapa Cad M 500 Tab
Rx

Dapa Cad M 500 Tab

Shrrishti Healthcare Products(I) Pvt Ltd - Tablet - 10 S

₹96

Prescription required

Rx

Eglucent Mix 25 Kwikpen

Lupin Lab - 3 ml

₹1,490

Prescription required

Rx

Empadus-10L Tab

Lividus Pharmaceuticals Pvt Ltd. - Tablet - 10 S

₹141

Prescription required

Empaverse L 25/5MG Tab
Rx

Empaverse L 25/5MG Tab

Verse Lifesciences - Tablet - 10 S

₹112

Prescription required

Euclide M 60 Od Tab
Rx

Euclide M 60 Od Tab

Alkem Lab - Tablet - 10

₹170

Prescription required

Rx

Glimda Mv 2 Tablet

Cipla Limited - Tablet - 10 Tablet

₹194

Prescription required

Popular on PingMeDoc Pharmacy

View categories
Vortiray 10MG
Rx

Vortiray 10MG

Icon Pharma - 10 mg - 10 S

₹178

Prescription required

Ebahist 10MG Tab
Rx

Ebahist 10MG Tab

East West Pharma - Tablet - 10 mg - 10 S

₹87

Prescription required

RxOut of stock

Paxiba 5MG Tab

Glenmark Pharmaceuticals - Tablet - 5 mg - 10 S

₹188

Prescription required

Lycor 1.0% Cream 15G
Rx

Lycor 1.0% Cream 15G

Micro Labs - Cream - 15 gm - 15 G

₹163

Prescription required

Dawnex Cap 10S
RxOut of stock

Dawnex Cap 10S

Micro Labs - Capsule - 10 S

₹30

Prescription required

Rx

Smartinor Cr 10MG

Walter Bushnel - 10 mg - 10 S

₹301

Prescription required

Momtop Cream
RxOut of stock

Momtop Cream

Brinton Pharmaceuticals Pvt Ltd - Cream - 15 G

₹164

Prescription required

Kenacort 40MG Vial
Rx

Kenacort 40MG Vial

Abbott Healthcare Pvt Ltd - Vial - 40 mg - Vial

₹212

Prescription required

Glimisave Mv 3.3 FAQs

What is Glimisave Mv 3.3 used for?
Glimisave Mv 3.3 is commonly used for Glimisave MV 3.3 Tablet SR is used in the treatment of type 2 diabetes. Always follow your doctor's advice, this information is for educational purposes and not a substitute for professional medical guidance.
What is the salt in Glimisave Mv 3.3?
Glimisave Mv 3.3 contains Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg). If you are allergic to any of these active ingredients or excipients, do not take this medicine and speak to your doctor first.
How should I take Glimisave Mv 3.3?
Take this medicine in the dose and duration as advised by your doctor. Take it exactly as prescribed; do not change the dose or stop early without talking to your doctor.
How does Glimisave Mv 3.3 work?
Glimisave MV 3.3 Tablet SR is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose.
Is Glimisave Mv 3.3 a prescription medicine?
Yes. Glimisave Mv 3.3 is a prescription-only (Rx) medicine. Upload a valid prescription from a registered medical practitioner during checkout. We cannot dispense it without a valid Rx.
What are the common side effects of Glimisave Mv 3.3?
The side effects reported most often with Glimisave Mv are Hypoglycemia (low blood sugar level) Nausea Diarrhea Taste change Flatulence Stomach pain Headache Skin rash Respiratory tract infection. Most are mild and settle as the body adjusts; tell your doctor if any of them persist or worry you, and stop the medicine and seek help at once for a rash, swelling of the face or lips, or difficulty breathing.
Can Glimisave Mv 3.3 be taken during pregnancy?
Glimisave MV 3.3 Tablet SR may be unsafe to use during pregnancy.<br>Animal studies have shown adverse effects on the foetus, however, there are limited human studies. Always tell your doctor if you are pregnant, planning a pregnancy or breastfeeding before starting Glimisave Mv.
Can I drink alcohol while taking Glimisave Mv 3.3?
Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
What if I miss a dose of Glimisave Mv 3.3?
Take it as soon as you remember.
Is Glimisave Mv 3.3 habit forming?
No. Glimisave Mv 3.3 is not known to be habit forming when taken as prescribed.
How much does Glimisave Mv 3.3 cost on PingMeDoc Pharmacy?
Glimisave Mv 3.3 starts at ₹165 on PingMeDoc Pharmacy. Available in NA 10`S. Final price is confirmed at checkout and may vary by variant and location.
Who manufactures Glimisave Mv 3.3?
Glimisave Mv 3.3 is manufactured by ERIS LIFE SCIENCES PVT LTD. PingMeDoc Pharmacy sources medicines only from licensed manufacturers and distributors.
How is Glimisave Mv 3.3 delivered?
Glimisave Mv 3.3 is delivered across India via our licensed pharmacy partners. Standard delivery timelines are confirmed at checkout. Chennai customers can opt for chargeable same-city express delivery.

Glimisave Mv 3.3, Quick facts

Salt
Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg)
Best price
₹165
Prescription
Required (Rx)
Schedule
Schedule H
Brand
ERIS LIFE SCIENCES PVT LTD
Manufacturer
ERIS LIFE SCIENCES PVT LTD
Therapeutic class
Anti-diabetic
Drug class
Biguanide, Oral anti-diabetic and Sulfonylurea
Habit forming
No
Variants
NA 10`S
Delivery
Standard across India

References

The information on Glimisave Mv 3.3 is compiled from the manufacturer's prescribing information and the sources below, and is reviewed by a registered medical practitioner. It does not replace advice from your own doctor.

  1. PingMeDoc clinical monograph library — compiled from Indian package inserts, the Indian Pharmacopoeia
  2. CDSCO schedules and standard pharmacology references. Reviewed for patient readability. This is general information, not a substitute for your doctor's advice.
  3. Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare, Government of India, approved drug and schedule listings.
  4. National List of Essential Medicines (NLEM) 2022, Government of India.
  5. Manufacturer's package insert / prescribing information for Glimisave Mv 3.3.
  6. World Health Organization, ATC/DDD classification and Model Formulary for the active ingredient.

Next steps

Safety disclaimer

Product information is for general awareness and does not replace professional medical advice. Always follow a clinician's guidance and upload a valid prescription when required.